Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,150 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $298.55 | 10 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $213.89 | 25 | $0 (2018) |
| Alkermes, Inc. | $136.65 | 2 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $125.79 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $91.31 | 1 | $0 (2024) |
| Indivior Inc. | $61.92 | 3 | $0 (2024) |
| Lundbeck LLC | $36.10 | 2 | $0 (2017) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34.82 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $31.92 | 2 | $0 (2022) |
| Axsome Therapeutics, Inc. | $29.48 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $576.34 | 14 | Vanda Pharmaceuticals Inc. ($125.79) |
| 2023 | $22.78 | 1 | BioXcel Therapeutics, Inc. ($22.78) |
| 2022 | $109.14 | 5 | Indivior Inc. ($46.05) |
| 2021 | $12.61 | 1 | Otsuka America Pharmaceutical, Inc. ($12.61) |
| 2018 | $101.61 | 11 | Sunovion Pharmaceuticals Inc. ($101.61) |
| 2017 | $327.71 | 21 | Otsuka America Pharmaceutical, Inc. ($153.36) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $124.58 | General |
| Category: CNS | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $125.79 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $91.31 | General |
| 05/30/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: PSYCHIATRY | ||||||
| 05/02/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: PSYCHIATRY | ||||||
| 04/19/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: PSYCHIATRY | ||||||
| 04/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: PSYCHIATRY | ||||||
| 03/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: PSYCHIATRY | ||||||
| 01/15/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: BH | ||||||
| 03/08/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: BH | ||||||
| 09/15/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Neuroscience | ||||||
| 06/26/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Central Nervous System | ||||||
| 01/07/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: BH | ||||||
| 11/11/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: CNS | ||||||
| 08/13/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: CNS | ||||||
| 06/19/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: CNS | ||||||
| 05/23/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.22 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 117 | 193 | $30,603 | $8,167 |
| 2022 | 3 | 145 | 227 | $36,185 | $9,300 |
| 2021 | 3 | 121 | 200 | $31,312 | $8,084 |
| 2020 | 3 | 90 | 150 | $23,904 | $6,726 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 45 | 108 | $13,392 | $3,694 | 27.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 36 | 44 | $7,084 | $2,450 | 34.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 36 | 41 | $10,127 | $2,023 | 20.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 54 | 126 | $15,624 | $3,365 | 21.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 47 | 50 | $12,350 | $3,334 | 27.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 44 | 51 | $8,211 | $2,601 | 31.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 45 | 110 | $13,640 | $2,796 | 20.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 41 | 53 | $8,533 | $2,670 | 31.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 35 | 37 | $9,139 | $2,618 | 28.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 30 | 35 | $8,645 | $2,638 | 30.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 35 | 88 | $10,912 | $2,629 | 24.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 25 | 27 | $4,347 | $1,458 | 33.6% |
About Dr. Grace Thomas, MD
Dr. Grace Thomas, MD is a Psychiatry healthcare provider based in Manhattan, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104860782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Grace Thomas, MD has received a total of $1,150 in payments from pharmaceutical and medical device companies, with $576.34 received in 2024. These payments were reported across 53 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,150).
As a Medicare-enrolled provider, Thomas has provided services to 473 Medicare beneficiaries, totaling 770 services with total Medicare billing of $32,277. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Manhattan, KS
- Active Since 06/15/2006
- Last Updated 01/17/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1104860782
Products in Payments
- ABILIFY MAINTENA (Drug) $226.73
- LATUDA (Drug) $213.89
- FANAPT (Drug) $125.79
- LYBALVI (Drug) $124.58
- REXULTI (Drug) $72.78
- PERSERIS (Drug) $61.92
- CAPLYTA (Drug) $34.82
- INVEGA SUSTENNA (Drug) $31.92
- Auvelity (Drug) $29.48
- Azstarys (Drug) $27.36
- ABILIFY TABLET (Drug) $23.95
- IGALMI (Drug) $22.78
- VRAYLAR (Drug) $21.83
- AUSTEDO (Drug) $17.79
- Vivitrol 380 mg (Drug) $12.07
- TRINTELLIX (Drug) $11.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Manhattan
David Wichman, M.d, M.D
Psychiatry — Payments: $687,584
Padma Lassi, M.d, M.D
Psychiatry — Payments: $1,655
Aveekshit Tripathi, Md, MD
Psychiatry — Payments: $856.20
Lakshika Ranaweera, Md, MD
Psychiatry — Payments: $418.80
Krishan Lassi, Md, MD
Psychiatry — Payments: $222.46
Dr. Paul Browde, M.d, M.D
Psychiatry — Payments: $214.16